Picture of Charles River Laboratories International logo

CRL Charles River Laboratories International Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Charles River Laboratories International, fiscal year end - December 30th, USD millions except per share, conversion factor applied.

2019
December 28th
2020
December 26th
2021
December 25th
2022
December 31st
2023
December 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line254365399493480
Depreciation
Deferred Taxes
Non-Cash Items44.5-27.277.511.642.7
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital6.18-26.342.9-153-102
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities481547761620684
Capital Expenditures-141-167-229-325-319
Purchase of Fixed Assets
Other Investing Cash Flow Items-541-435-1,209-283-245
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-682-602-1,438-608-563
Financing Cash Flow Items-18.4-5.95-40.6-48.6-11.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities23247.2673-42.4-85.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash42.7-6.9313.2-5.143.3